IMAGE

Fig. S2

ID
ZDB-IMAGE-160816-15
Antibodies
Source
Figures for Venero Galanternik et al., 2015
Image
Figure Caption

Fig. S2

extl3/ext2 mutants show a late onset phenotype. Related to Figure 1-3.

(A-B′′) extl3/ext2 mutants show significant downregulation of HS chains as evidenced by 3G10 antibody whole mount staining. (C-F) LL phenotypes in 5 dpf extl3/ext2 mutants. Compared to ext2 and extl3/ext2 mutants, extl3 mutants show only mild defects in the LL at this stage of development (D). ext2 mutant primordia do not reach the tail tip by 5 dpf and possess an elongated tip but clear neuromast formation (E). extl3/ext2 mutants are characterized by a collapsed LL where all neuromasts have lost their round shape, likely due to the loss of Fgf signaling (F). (G-H′) Wnt/β-catenin targets lef1 and fgf3 are expanded along the whole lateral line in 3 dpf extl3/ext2 mutants. (I-K′) The Fgf target fgfr1 is progressively downregulated between 34 hpf and 3 dpf in extl3/ext2 mutants. (K′) Close up of a 48 hpf extl3/ext2 primordium showing the downregulated fgfr1 expression.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Rep.